COLL vs NVDA · P/E 17, rev $181.9M vs P/E 58, rev $96.22B
Collegium Pharmaceutical Inc (COLL) versus NVIDIA Corporation (NVDA) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
NVIDIA Corporation (NVDA) is a semiconductors company listed on US. It is led by Jensen Huang.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported NVDA revenue for 2026-07-26 was $96.22B. Net income was $59.69B. Revenue was up 17.9% from 2026-04-26 to 2026-07-26. NVDA currently screens at market cap $4.40T and trailing P/E 58.2.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. NVDA currently screens at market cap $4.40T and trailing P/E 58.2.
Not investment advice. Open the COLL and NVDA stock pages for the full models.
Not investment advice.